570
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Anti-inflammatory effects of potato extract on a rat model of cigarette smoke–induced chronic obstructive pulmonary disease

, , , , , , , , , , , & show all
Article: 28879 | Received 17 Jun 2015, Accepted 04 Sep 2015, Published online: 23 Oct 2015

References

  • Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002; 2: 372–7.
  • Vassallo R. Diffuse lung diseases in cigarette smokers. Semin Respir Crit Care. 2012; 33: 533–42.
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012; 379: 1341–51.
  • Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, etal. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2163–96.
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, etal. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095–128.
  • Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187: 347–65.
  • Hoepers AT, Menezes MM, Frode TS. Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol. 2015; 42: 231–9.
  • Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules. 2015; 5: 1266–83.
  • Tangedal S, Aanerud M, Persson LJ, Brokstad KA, Bakke PS, Eagan TM. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respir Res. 2014; 15: 138.
  • Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C, Godoy I. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Am J Med Sci. 2013; 345: 440–5.
  • de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF. Interleukin-6 and interleukin-8 blood levels’ poor association with the severity and clinical profile of ex-smokers with COPD. Int J Chron Obstruct Pulmon Dis. 2014; 9: 735–43. [PubMed Abstract] [PubMed CentralFull Text].
  • Ferrari R, Tanni SE, Caram LM, Corrêa C, Corrêa CR, Godoy I. Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res. 2013; 14: 24.
  • Zhang L, Cheng Z, Liu W, Wu K. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD. 2013; 10: 459–65.
  • Vlahos R., Bozinovski S, Hamilton JA, Anderson GP. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther. 2006; 112: 106–15.
  • Camire ME, Kubow S, Donnelly DJ. Potatoes and human health. Crit Rev Food Sci Nutr. 2009; 49: 823–40.
  • Turski MP, Kamiński P, Zgrajka W, Turska M, Turski WA. Potato- an important source of nutritional kynurenic acid. Plant Foods Hum Nutr. 2012; 67: 17–23.
  • Kenny OM, McCarthy CM, Brunton NP, Hossain MB, Rai DK, Collins SG, etal. Anti-inflammatory properties of potato glycoalkaloids in stimulated Jurkat and Raw 264.7 mouse macrophages. Life Sci. 2013; 92: 775–82.
  • Shim EH, Choung SY. Inhibitory effects of Solanum tuberosum L. var. vitelotte extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. J Pharm Pharmacol. 2014; 66: 1303–16.
  • Lee SJ, Shin JS, Choi HE, Lee KG, Cho YW, An HJ, etal. Chloroform fraction of Solanum tuberosum L. cv Jayoung epidermis suppresses LPS-induced inflammatory responses in macrophages and DSS-induced colitis in mice. Food Chem Toxicol. 2014; 63: 53–61.
  • Kaspar KL, Park JS, Brown CR, Mathison BD, Navarre DA, Chew BP. Pigmented potato consumption alters oxidative stress and inflammatory damage in men. J Nutr. 2011; 141: 108–11.
  • Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006; 28: 1245–57.
  • Juergens UR. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases. Drug Res (Stuttg). 2014; 64: 638–46.
  • Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, etal. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 2010; 335: 788–98.
  • Dong YH, Lin HH, Shau WY, Wu YC, Chang CH, Lai MS. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials. Thorax. 2013; 68: 48–56.
  • Rutten-van Molken MP, Goossens LM. Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues. Pharmacoeconomics. 2012; 30: 271–302.
  • Bai J, Qiu SL, Zhong XN, Huang QP, He ZY, Zhang JQ, etal. Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediators Inflamm. 2012; 2012: 410232. doi: http://dx.doi.org/10.1155/2012/410232 [PubMed Abstract] [PubMed CentralFull Text].
  • Wang Y, Jiang X, Zhang L, Wang L, Li Z, Sun W. Simvastatin mitigates functional and structural impairment of lung and right ventricle in a rat model of cigarette smoke-induced COPD. Int J Clin Exp Pathol. 2014; 7: 8553–62. [PubMed Abstract] [PubMed CentralFull Text].
  • Jung KH, Haam KK, Park S, Kim Y, Lee SR, Lee G, etal. The standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease. BMC Complement Altern Med. 2013; 13: 219. doi: http://dx.doi.org/10.1186/1472-6882-13-219 [PubMed Abstract] [PubMed CentralFull Text].
  • Lee E, Yun N, Jang YP, Kim J. Lilium lancifolium Thunb. extract attenuates pulmonary inflammation and air space enlargement in a cigarette smoke-exposed mouse model. J Ethnopharmacol. 2013; 149: 148–56.
  • Cogo R, Castronuovo A. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis. Eur Rev Med Pharmacol Sci. 2000; 4: 15–20. [PubMed Abstract].
  • Burge PS, Scheibe R, Wötzel M, Spencer S, Anderson JA. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax. 2003; 58: 654–8.
  • Gessner C, Scheibe R, Wötzel M, Hammerschmidt S, Kuhn H, Engelmann L, etal. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med. 2005; 99: 1229–40.
  • Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets. 2006; 7: 675–81.
  • Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104: 487–501.
  • Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008; 226: 205–18.
  • Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science. 1985; 229: 16–22.
  • Lyman GH, Dale DC, Culakova E, Poniewierski MS, Wolff DA, Kuderer NM, etal. The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2013; 24: 2475–84.
  • Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013; 13: 159–75.